VIRI - Pambiji Buku Bisnis Virios Therapeutics Inc.

Virios Therapeutics (VIRI) relies on robotic laboratories to ensure the most precise and safe drug testing. The company is developing a premium pricing strategy, offering a unique treatment for fibromyalgia and CFS by suppressing herpes viruses in the CNS. The current metric stands at 0.00, while the operating cycle is constrained by FDA waste disposal regulations. The available price action vector for analysis is presented below.

VIRI Kapitalisasi Buku Virios Therapeutics, Inc. (04.07.2022 - 09.10.2024)

Rincian metrik lan analitis perusahaan Virios (VIRI)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega Virios Therapeutics|VIRI - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Virios Therapeutics Inc.|VIRI - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham Virios Therapeutics|VIRI - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku virios.com|VIRI - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Virios Therapeutics|VIRI - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Virios Therapeutics|VIRI - Utang perusahaan|Utang marang nilai buku Virios Therapeutics Inc.|VIRI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Virios Therapeutics

Pambiji fundamental:VIRI - Virios Therapeutics, Inc.

Book value capitalization determines the value of the issuer's net assets minus all liabilities, serving as a fundamental filter for assessing the real value of a business. An analysis of the current book capital of Virios Therapeutics (VIRI) allows for a comparison of the tangible asset base against the value of unique developments in fibromyalgia therapy, helping investors avoid overpaying for speculative price growth.

Analisis pesaing Virios Therapeutics